Non-Invasive Monitoring Systems Stock

Non-Invasive Monitoring Systems ROIC

The Return on Invested Capital (ROIC) of Non-Invasive Monitoring Systems (NIMU) as of Sep 4, 2026 is 63.07 %. In the previous year, Return on Invested Capital (ROIC) was 50.22 % — a change of 25.58% (higher).

ROIC

63.07 %

YoY

25.58%

Last updated:

Return on Invested Capital (ROIC) of Non-Invasive Monitoring Systems is 2026 63.07 % . Return on Invested Capital (ROIC) of Non-Invasive Monitoring Systems was 2025 50.22 % . It decreases by 25.58% higher compared to the previous year.

The Non-Invasive Monitoring Systems ROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROIC
Date
ROIC
Jan 1, 2018
28.65 USD
Jan 1, 2019
-1,993.83 USD
Jan 1, 2020
198.78 USD
Jan 1, 2021
65.83 USD
Jan 1, 2022
65.78 USD
Jan 1, 2023
63.78 USD
Jan 1, 2024
50.22 USD
Jan 1, 2025
63.07 USD
The Non-Invasive Monitoring Systems ROIC history
YEARROICYoY
63.07 %+25.58%
50.22 %-21.26%
63.78 %-3.04%
65.78 %-0.08%
65.83 %-66.88%
198.78 %-109.97%
-1,993.83 %-7,058.23%
28.65 %-17.33%
34.66 %-52.29%
72.65 %+4.97%
69.21 %-38.66%
112.82 %
Access this data via the Eulerpool API

Non-Invasive Monitoring Systems Stock analysis

What does Non-Invasive Monitoring Systems do? Non-Invasive Monitoring Systems Inc (NIMS) has become a major player in the field of medical diagnostics and monitoring in recent years. The company was founded in 2002 and is headquartered in Miami, Florida. Its focus is on developing and marketing innovative non-invasive technologies that enable better patient care. NIMS' business model is based on the development and marketing of products that allow for fast and accurate diagnosis of various medical conditions. These technologies can be used in various clinical areas such as intensive care, oncology, cardiology, and neurology. The company's goal is to improve patient care by making diagnostics and monitoring faster, more accurate, and more effective. NIMS has several divisions that focus on different medical applications. One of these is the gastrointestinal division, which specializes in the diagnosis and monitoring of gastrointestinal disorders. NIMS offers innovative technologies such as magnetic resonance elastography (MRE-MRI), which allows for the measurement of tissue hardness without invasive procedures. This technology is particularly used in the early detection of cancer, as it enables the detection of tissue changes at an early stage. Another important division of NIMS is cardiovascular monitoring, which aims at the early detection and monitoring of heart diseases. The company offers various non-invasive technologies for this purpose, such as wearable devices for measuring blood pressure and heart rate, or ultrasound for measuring blood flow and vascular stiffness. These technologies are intended to improve the monitoring of patients with heart diseases and to detect complications at an early stage. NIMS also offers innovative diagnostic tools for the early detection of cancer, such as the Cancer Screening Index (CSI). The CSI is a biomarker-based test that calculates the probability of developing certain types of cancer. Various factors such as family history, smoking, or age are taken into account in the calculation. The CSI aims to contribute to the early detection of cancer and thus enable better prognosis. In addition to these products, NIMS is also involved in clinical research. The company offers specialized services such as conducting clinical trials or providing expert opinions. These services are intended to promote the development of new non-invasive diagnostic and monitoring technologies and thus improve overall patient care. Overall, NIMS has become a leading company in the field of non-invasive medical diagnostics and monitoring. The company is constantly striving to advance the development of new innovative technologies to improve patient care and minimize the use of invasive procedures. With its various divisions and products, NIMS is able to cover various medical applications and thus appeal to a broad customer base. Non-Invasive Monitoring Systems is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Non-Invasive Monitoring Systems stock

Return on Invested Capital (ROIC) of Non-Invasive Monitoring Systems is 63.07 % in 2026.

Return on Invested Capital (ROIC) of Non-Invasive Monitoring Systems changed from 50.22 % to 63.07 %, representing a 25.58% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Invested Capital (ROIC) Non-Invasive Monitoring Systems since 2006 – with annual values, charts, and detailed analysis.

ROIC measures how effectively a company uses its invested capital to generate profits. A ROIC above the cost of capital creates shareholder value.

ROIC = NOPAT / Invested Capital

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Invested Capital (ROIC)'s Non-Invasive Monitoring Systems with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Invested Capital (ROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Invested Capital (ROIC).

Access this data via the Eulerpool API

Profitability — Non-Invasive Monitoring Systems

All Key Metrics — Non-Invasive Monitoring Systems